Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

about

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review

P2860

Q28109657-890DE188-1207-490A-8C07-4C71A44CAAAA

P2860

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

Item

http://www.wikidata.org/entity/Q42215418

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

@en

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

@nl

type

Item

label

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

@en

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

@nl

prefLabel

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

@en

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

@nl

P1476

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy

@en

P2093

D J Back

http://www.w3.org/2001/XMLSchema#string

L J Else

http://www.w3.org/2001/XMLSchema#string

M Brennan

http://www.w3.org/2001/XMLSchema#string

S Coulter-Smith

http://www.w3.org/2001/XMLSchema#string

V Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

Atazanavir pharmacokinetics with and without tenofovir during pregnancy

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy

Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review.

Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.

Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.

Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.

Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

British HIV Association guidelines for the management of HIV infection in pregnant women 2012

P304

604-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIV.12164

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John S Lambert

S Khoo

P577

2014-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24825070

http://www.w3.org/2001/XMLSchema#string

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

about

P2860

P2860

Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698